Clinical trials
Phase 3 Anemia, Refractory, with Excess of Blasts trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Traws Pharma, Inc. | 3 |
| National Cancer Institute (NCI) | 2 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Medical College of Wisconsin | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Neovii Biotech | 1 |
| SWOG Cancer Research Network | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 14 |
| Myelodysplastic Syndromes | 9 |
| Leukemia, Myelomonocytic, Chronic | 6 |
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Anemia, Refractory | 3 |
| Lymphoma | 3 |
| Myeloproliferative Disorders | 3 |
| Congenital Abnormalities | 2 |
| Leukemia, Erythroblastic, Acute | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.